NC

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.58B
AUM Growth
+$298M
Cap. Flow
-$45M
Cap. Flow %
-0.98%
Top 10 Hldgs %
20.03%
Holding
233
New
17
Increased
71
Reduced
108
Closed
8
Avg Time Held
2.6 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
2.1 years

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$30M
2
CMCSA icon
Comcast
CMCSA
+$21.7M
3
DGX icon
Quest Diagnostics
DGX
+$18M
4
SNN icon
Smith & Nephew
SNN
+$15.7M
5
RVTY icon
Revvity
RVTY
+$12M

Top Sells

Rank Stock Value
1
PARA icon
Paramount Global Class B
PARA
+$35.9M
2
TMO icon
Thermo Fisher Scientific
TMO
+$13.6M
3
KDP icon
Keurig Dr Pepper
KDP
+$13.6M
4
MA icon
Mastercard
MA
+$12.6M
5
CAVM
Cavium, Inc.
CAVM
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 20.49%
2 Healthcare 18.23%
3 Consumer Discretionary 14.59%
4 Financials 14.49%
5 Industrials 13.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.01T
$114M 2.5%
2,026,040
-33,200
-2% -$1.73M
2016 Q1
10 quarters
MSFT icon
2
Microsoft
MSFT
$3.96T
$111M 2.43%
973,400
-70,840
-7% -$7.68M
2013 Q2
21 quarters
SNA icon
3
Snap-on
SNA
$18.8B
$106M 2.31%
575,200
-5,010
-0.9% -$873K
2013 Q2
21 quarters
CSCO icon
4
Cisco
CSCO
$448B
$105M 2.29%
2,152,520
-3,000
-0.1% -$135K
2016 Q3
8 quarters
TMO icon
5
Thermo Fisher Scientific
TMO
$249B
$93.7M 2.05%
383,859
-59,195
-13% -$13.6M
2013 Q2
21 quarters
MA icon
6
Mastercard
MA
$528B
$84.5M 1.85%
379,705
-60,480
-14% -$12.6M
2013 Q2
21 quarters
SCHW icon
7
Charles Schwab
SCHW
$167B
$78.9M 1.72%
1,605,895
– –
2016 Q3
8 quarters
CTAS icon
8
Cintas
CTAS
$82.8B
$76M 1.66%
1,537,440
-131,980
-8% -$6.82M
2016 Q4
7 quarters
AON icon
9
Aon
AON
$58.4B
$74.5M 1.63%
484,370
-22,540
-4% -$3.3M
2013 Q2
21 quarters
ORLY icon
10
O'Reilly Automotive
ORLY
$70.1B
$73.2M 1.6%
3,162,465
-149,550
-5% -$3.18M
2013 Q2
21 quarters
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.2T
$73.1M 1.6%
1,224,200
– –
2016 Q4
7 quarters
FTV icon
12
Fortive
FTV
$17.3B
$69.3M 1.51%
1,305,172
-23,881
-2% -$1.22M
2016 Q3
8 quarters
LKQ icon
13
LKQ Corp
LKQ
$5.52B
$68.9M 1.51%
2,176,612
+70,350
+3% +$2.34M
2013 Q2
21 quarters
FAST icon
14
Fastenal
FAST
$59.7B
$68.6M 1.5%
4,727,560
-841,100
-15% -$12M
2013 Q2
21 quarters
V icon
15
Visa
V
$735B
$67.7M 1.48%
451,350
-30
-0% -$4.27K
2016 Q3
8 quarters
AMZN icon
16
Amazon
AMZN
$2.74T
$64.7M 1.41%
645,900
-45,100
-7% -$4.24M
2017 Q1
6 quarters
CBRE icon
17
CBRE Group
CBRE
$37.3B
$64M 1.4%
1,450,270
-156,405
-10% -$7.46M
2013 Q2
21 quarters
HD icon
18
Home Depot
HD
$295B
$63.1M 1.38%
304,830
-8,545
-3% -$1.72M
2016 Q4
7 quarters
TJX icon
19
TJX Companies
TJX
$157B
$62.9M 1.37%
1,122,940
-39,000
-3% -$2M
2017 Q4
3 quarters
PFE icon
20
Pfizer
PFE
$166B
$55.1M 1.2%
1,318,022
-34,782
-3% -$1.34M
2013 Q2
21 quarters
INTC icon
21
Intel
INTC
$519B
$55.1M 1.2%
1,165,010
-192,630
-14% -$9.37M
2017 Q1
6 quarters
MDT icon
22
Medtronic
MDT
$121B
$54.5M 1.19%
554,420
– –
2016 Q3
8 quarters
WBA icon
23
DELISTED
Walgreens Boots Alliance
WBA
$54.2M 1.18%
742,870
-5,050
-0.7% -$343K
2013 Q2
21 quarters
LH icon
24
Labcorp
LH
$25.7B
$53.6M 1.17%
359,531
– –
2016 Q1
10 quarters
EPD icon
25
Enterprise Products Partners
EPD
$77.3B
$53.3M 1.16%
1,855,580
-60
-0% -$1.73K
2015 Q4
11 quarters
1
2 3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q3 2018 Portfolio in Review

As of Q3 2018, Nicholas Company held 233 positions worth $4.58B, up 7% from $4.28B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Company's Q3 2018 filing shows 17 new, 71 increased, 108 reduced and 8 closed positions. Its largest new stake was Intercontinental Exchange: 399,515 shares worth $29.9M. The largest sale was Paramount Global Class B, an estimated $35.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nicholas Company's largest Q3 2018 buy was Intercontinental Exchange: 399,515 shares worth $29.9M.
  • Nicholas Company added most to Quest Diagnostics in Q3 2018, an estimated $18M increase.
  • Nicholas Company's biggest Q3 2018 reduction was Thermo Fisher Scientific, cutting an estimated $13.6M.
  • Nicholas Company fully exited Paramount Global Class B in Q3 2018, selling an estimated $35.9M.
  • Nicholas Company's ten largest holdings make up 20% of its $4.58B portfolio in Q3 2018.
  • Nicholas Company opened 17 new positions and closed 8 in Q3 2018.
  • Nicholas Company's portfolio value rose 7% quarter-over-quarter to $4.58B.

Based on Nicholas Company's 13F filing for Q3 2018, filed 14 Nov 2018.